Prioritize for COVID‐19 testing: (1) patients with cirrhosis, (2) patients with CLD receiving immunosuppressive medications, and (3) patients with new‐onset encephalopathy or other acute decompensation
Regularly monitor liver biochemistries
Consider non‐COVID‐19 etiologies for liver disease: (1) exacerbation of preexisting CLD or (2) drug‐induced hepatotoxicity
Use acetaminophen 2 g/day as preferred medication
Use nonsteroidal anti‐inflammatory drugs as needed
Consult the University of Liverpool document to assess possible drug interactions